CIK 0001668397
- Large accelerated filer
Medpace Holdings, Inc.
Sign in to watch- Ticker
- MEDP
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 320434904
- Phone
- +1 513-579-9911
- Business address
- 5375 MEDPACE WAY, CINCINNATI, OH, 45227
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $174,850,299
- in 14 filings
Net −$174,850,299. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-28 | Troendle August J. CEO | Sale | −50,000 | $404.13 | $20.2M | 5,133,019 |
| 2024-02-28 | Medpace Investors, LLC 10% owner | Sale | −50,000 | $404.13 | $20.2M | 5,133,019 |
| 2024-02-27 | Troendle August J. CEO | Sale | −50,000 | $401.88 | $20.1M | 5,183,019 |
| 2024-02-27 | Medpace Investors, LLC 10% owner | Sale | −50,000 | $401.88 | $20.1M | 5,183,019 |
| 2024-02-26 | Keating Ashley M. Director | Exercise or conversion | +500 | $54.99 | $27K | 500 |
| 2024-02-26 | Keating Ashley M. Director | Sale | −246 | $403.89 | $99K | 254 |
| 2024-02-26 | Keating Ashley M. Director | Sale | −254 | $404.68 | $103K | 0 |
| 2024-02-26 | Keating Ashley M. Director | Exercise or conversion · Stock Option (Right to Buy) | −500 | 972 | ||
| 2024-02-26 | Troendle August J. CEO | Sale | −56,928 | $402.38 | $22.9M | 5,233,019 |
| 2024-02-26 | Medpace Investors, LLC 10% owner | Sale | −56,928 | $402.38 | $22.9M | 5,233,019 |
| 2024-02-23 | Troendle August J. CEO | Sale | −100,000 | $400.32 | $40.0M | 5,289,947 |
| 2024-02-23 | Medpace Investors, LLC 10% owner | Sale | −100,000 | $400.32 | $40.0M | 5,289,947 |
| 2024-02-22 | Medpace Investors, LLC 10% owner | Sale | −100,000 | $395.98 | $39.6M | 5,389,947 |
| 2024-02-22 | Troendle August J. CEO | Sale | −100,000 | $395.98 | $39.6M | 5,389,947 |
| 2024-02-21 | Medpace Investors, LLC 10% owner | Sale | −36,012 | $383.44 | $13.8M | 5,489,947 |
| 2024-02-21 | Troendle August J. CEO | Sale | −36,012 | $383.44 | $13.8M | 5,489,947 |
| 2024-02-20 | Carley Brian T Director | Exercise or conversion | +13,782 | $26.44 | $364K | 21,595 |
| 2024-02-20 | Carley Brian T Director | Exercise or conversion · Stock Option (Right to Buy) | −13,782 | 0 | ||
| 2024-02-20 | Medpace Investors, LLC 10% owner | Sale | −13,988 | $386.39 | $5.4M | 5,525,959 |
| 2024-02-20 | Troendle August J. CEO | Sale | −13,988 | $386.39 | $5.4M | 5,525,959 |
Page 17 of 20 · 391 trades